arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Ceribell, Inc.

CBLL
$23.62 ▼ -0.62 (-2.56%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
15 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Ceribell, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $898.3M
Dividend Yield
Revenue Growth 32.5%
Op. Margin -71.1%
ROIC -15.6%
FCF / Share $-0.34
Trailing P/E
Price / Book 7.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

15-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$28.10M
↑ +32.5%
Net Income Profit after all expenses
$-19.74M
↓ -54.5%
Operating Margin Operating profit as % of sales
-71.1%
↑ +9.2% 4th
FCF / Share Free cash flow per share
$-0.34
↓ -61.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
21
Financial Health
21
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 4 years · 15 quarters